SCHEMBL25047546

SCHEMBL25047546

Nc1nc(Cl)nc2c1c(Br)cn2C1CCC(C2CCN(CC3CC3)CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25048601 0.83 DRD4 (0.36) —
SCHEMBL25046685 0.82 METTL3 (0.35) —
SCHEMBL25047545 0.81 METTL3 (0.38) —
SCHEMBL30941158 0.81 METTL3 (0.38) —
SCHEMBL25048624 0.79 ACHE (0.30) —
SCHEMBL25047967 0.78 PRMT5 (0.43) —
SCHEMBL25047572 0.76 IGF1R (0.33) —
SCHEMBL25047575 0.75 NAMPT (0.30) —
SCHEMBL25047513 0.74 ALOX15 (0.34) —
SCHEMBL25048921 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023017152-A1 SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) 2023-02-16 — — WO disclosed
Send feedback